Zhi-Qiang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhi-Qiang Zhang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Donghwa Chung
2 shared publications- Soo-Chang Song
Center for Biomaterials, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea
2 shared publications - Chen Yang
College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin 300457, China
1 shared publication Cheol-Ho Pan
1 shared publicationJianming Wang
1 shared publicationSoo-Chang Song
Center for Biomaterials , Korea Institute of Science and Technology , Seoul 02792 , Republic of Korea
1 shared publication
Latest Publications
- 2 September 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (38) , 34634-34644
Injectable and Quadruple-Functional Hydrogel as an Alternative to Intravenous Delivery for Enhanced Tumor Targeting
Intravenous (IV) route is most commonly used drug delivery approach. However, the targeting efficiency to tumor through IV delivery is usually less than 10%. To address this limitation, we report a new systemic delivery method utilizing injectable and quadruple-functional hydrogels to improve targeting efficiency through passive, active, and magnetic targeting, and hydrogel-controlled sustained release. The hydrogels consist of a folate/polyethylenimine-conjugated poly(organophosphazene) polymer, which encapsulates small interfering RNA (siRNA) and Au–Fe3O4 nanoparticles to form a nanocapsule (NC) structure by a simple mixing. The hydrogels are localized as a long-term ‘drug-release depot’ after a single subcutaneous injection and sol-gel phase transition. NCs released from the hydrogels enter the circulatory systems and then target the tumor through EPR/folate/magnetism triple targeting, over the course of circulation, itself prolonged by the controlled release. In vivo experiments show that 12% of NCs are successfully delivered to the tumor, which is a considerable improvement as compared to most results through intravenous delivery. The sustained targeting of gold to tumor enables two cycles of photothermal therapy, resulting in an enhanced silencing effect of siRNA and considerable reduction of tumor volume, which we are unable to achieve via simple intravenous injection.
- 2 September 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (38) , 34634-34644
Injectable and Quadruple-Functional Hydrogel as an Alternative to Intravenous Delivery for Enhanced Tumor Targeting
Intravenous (IV) route is most commonly used drug delivery approach. However, the targeting efficiency to tumor through IV delivery is usually less than 10%. To address this limitation, we report a new systemic delivery method utilizing injectable and quadruple-functional hydrogels to improve targeting efficiency through passive, active, and magnetic targeting, and hydrogel-controlled sustained release. The hydrogels consist of a folate/polyethylenimine-conjugated poly(organophosphazene) polymer, which encapsulates small interfering RNA (siRNA) and Au–Fe3O4 nanoparticles to form a nanocapsule (NC) structure by a simple mixing. The hydrogels are localized as a long-term ‘drug-release depot’ after a single subcutaneous injection and sol-gel phase transition. NCs released from the hydrogels enter the circulatory systems and then target the tumor through EPR/folate/magnetism triple targeting, over the course of circulation, itself prolonged by the controlled release. In vivo experiments show that 12% of NCs are successfully delivered to the tumor, which is a considerable improvement as compared to most results through intravenous delivery. The sustained targeting of gold to tumor enables two cycles of photothermal therapy, resulting in an enhanced silencing effect of siRNA and considerable reduction of tumor volume, which we are unable to achieve via simple intravenous injection.
- 1 July 2017
- Published by Elsevier in Biomaterials
- Vol. 132, 16-27
Multiple hyperthermia-mediated release of TRAIL/SPION nanocomplex from thermosensitive polymeric hydrogels for combination cancer therapy
- 1 July 2017
- Published by Elsevier in Biomaterials
- Vol. 132, 16-27
Multiple hyperthermia-mediated release of TRAIL/SPION nanocomplex from thermosensitive polymeric hydrogels for combination cancer therapy
- 1 November 2016
- Published by Elsevier in Biomaterials
- Vol. 106, 13-23
Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia
- 1 November 2016
- Published by Elsevier in Biomaterials
- Vol. 106, 13-23
Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia
- 1 May 2011
- Published by Elsevier in Food Research International
- Vol. 44 (4) , 1000-1007
Tannic acid cross-linked gelatin–gum arabic coacervate microspheres for sustained release of allyl isothiocyanate: Characterization and in vitro release study
- 1 May 2011
- Published by Elsevier in Food Research International
- Vol. 44 (4) , 1000-1007
Tannic acid cross-linked gelatin–gum arabic coacervate microspheres for sustained release of allyl isothiocyanate: Characterization and in vitro release study
- 1 February 2010
- Published by Elsevier in Journal of Food Engineering
- Vol. 96 (4) , 628-633
Thermodynamics of partitioning of allyl isothiocyanate in oil/air, oil/water, and octanol/water systems
- 1 February 2010
- Published by Elsevier in Journal of Food Engineering
- Vol. 96 (4) , 628-633
Thermodynamics of partitioning of allyl isothiocyanate in oil/air, oil/water, and octanol/water systems